Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection: The Phase 2 DURVAST Study.
暂无分享,去创建一个
B. Clotet | J. Martinez-Picado | J. Prado | A. Meyerhans | R. Rosell | J. Blanco | B. Massuti | M. Provencio | J. Carrillo | J. Argilaguet | Chung-Ying Huang | P. Cao | J. Bracht | M. Molina-Vila | T. Morán | J. De Castro | R. Bernabé | A. Drozdowskyj | J. Garcia-Corbacho | J. Dalmau | M. Gonzalez-Cao | Ó. Juan | R. Blanco | Clara Mayo de Las Casa | M. Garzón | M. González-Cao | J. de Castro | Mónica Garzón | chung-Ying Huang | B. Massutí | J. García-Corbacho